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Ambulatory systolic blood pressure and
obesity are independently associated with
left ventricular hypertrophic remodeling in
children
Linyuan Jing1,2, Christopher D. Nevius1,2, Cassi M. Friday1,2, Jonathan D. Suever1,2, Arichanah Pulenthiran1,2,
Abba Mejia-Spiegeler1,2, H. Lester Kirchner2, William J. Cochran3, Gregory J. Wehner4, Aftab S. Chishti5,
Christopher M. Haggerty1,2 and Brandon K. Fornwalt1,2,6*
Abstract
Background: Children with obesity have hypertrophic cardiac remodeling. Hypertension is common in pediatric
obesity, and may independently contribute to hypertrophy. We hypothesized that both the degree of obesity and
ambulatory blood pressure (ABP) would independently associate with measures of hypertrophic cardiac remodeling
in children.
Methods: Children, aged 8–17 years, prospectively underwent cardiovascular magnetic resonance (CMR) and ABP
monitoring. Left ventricular (LV) mass indexed to height2.7 (LVMI), myocardial thickness and end-diastolic volume
were quantified from a 3D LV model reconstructed from cine balanced steady state free precession images.
Categories of remodeling were determined based on cutoff values for LVMI and mass/volume. Principal component
analysis was used to define a “hypertrophy score” to study the continuous relationship between concentric hypertrophy
and ABP.
Results: Seventy-two children were recruited, and 68 of those (37 healthy weight and 31 obese/overweight)
completed both CMR and ABP monitoring. Obese/overweight children had increased LVMI (27 ± 4 vs 22 ± 3 g/
m2.7, p < 0.001), myocardial thickness (5.6 ± 0.9 vs 4.9 ± 0.7 mm, p < 0.001), mass/volume (0.69 ± 0.1 vs 0.61 ± 0.
06, p < 0.001), and hypertrophy score (1.1 ± 2.2 vs −0.96 ± 1.1, p < 0.001). Thirty-five percent of obese/overweight
children had concentric hypertrophy. Ambulatory hypertension was observed in 26% of the obese/overweight children
and none of the controls while masked hypertension was observed in 32% of the obese/overweight children
and 16% of the controls. Univariate linear regression showed that BMI z-score, systolic BP (24 h, day and
night), and systolic load correlated with LVMI, thickness, mass/volume and hypertrophy score, while 24 h and
nighttime diastolic BP and load also correlated with thickness and mass/volume. Multivariate analysis showed
body mass index z-score and systolic blood pressure were both independently associated with left ventricular
mass index (β=0.54 [p < 0.001] and 0.22 [p = 0.03]), thickness (β=0.34 [p < 0.001] and 0.26 [p = 0.001]) and
hypertrophy score (β=0.47 and 0.36, both p < 0.001).
(Continued on next page)
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Conclusions: In children, both the degree of obesity and ambulatory blood pressures are independently associated
with measures of cardiac hypertrophic remodeling, however the correlations were generally stronger for the degree of
obesity. This suggests that interventions targeted at weight loss or obesity-associated co-morbidities including
hypertension may be effective in reversing or preventing cardiac remodeling in obese children.
Keywords: Pediatric obesity, Ventricular remodeling, Hypertension, Cardiovascular magnetic resonance, Ambulatory
blood pressure monitoring
Background
Childhood obesity affects 17% of children and adolescents
(2–19 years) in the United States [1], and is associated with
increased risk of cardiovascular disease and premature
death [2, 3]. Although severe cardiovascular disease is rare
in children, early signs of heart disease in obese/overweight
children have been documented [4–7]. The most common
findings include increased left ventricular (LV) mass and
wall thickness. In addition, approximately 25% of obese/
overweight children have concentric hypertrophy [7, 8].
These changes are worrisome as both increased LV mass
and concentric hypertrophy have been related to increased
cardiovascular risk and premature death in adults [9].
Mechanisms underlying hypertrophic cardiac remodel-
ing in obese children are not well understood, at least in
part because several obesity co-morbidities, particularly
high blood pressure (BP), are known to independently
cause LV hypertrophy [10]. High systolic BP, defined as
systolic BP ≥95th percentile for height and sex [11], has a
prevalence of up to 20% in obese/overweight children
[12]. Elevated BP has also been independently associated
with LV hypertrophy in childhood [13–15], and therefore
increased risk for future adult cardiovascular disease [16].
Hypertension is commonly diagnosed with a repeated
[11] clinic measurement (often referred to as casual
hypertension), however, this approach provides poor
characterization of actual BP [17]. Ambulatory blood
pressure (ABP) monitoring provides a more accurate and
comprehensive assessment of BP over a 24-h period. Pre-
vious studies have shown that compared to clinic BP, ABP
has a stronger correlation with target organ damage (such
as LV mass) in adults [18]. In addition, white-coat hyper-
tension (elevated clinical BP but normal ambulatory BP
(ABP) levels) and masked hypertension (normal clinic BP
with elevated ABP levels) can only be diagnosed by ABP
monitoring. Previous studies have reported a prevalence
of 22–32% for white-coat and 7–32% for masked hyper-
tension in children [19].
The relationship between ABP and LV hypertrophy in
obese children is not well understood. A few studies using
ABP monitoring have shown a positive correlation be-
tween systolic BP and increased LVMI [13–15, 20]. How-
ever, these studies either did not evaluate the independent
effect of obesity [20], or were conducted on biased
populations (children with casual hypertension [13], at
risk for hypertension [14], or with other complications
[15]). To our knowledge, no study has comprehensively
investigated the relationship between obesity, ABP and
measures of cardiac remodeling in otherwise healthy
children.
In addition, all previous studies used echocardiography
to assess LV mass and/or thickness. Transthoracic eho-
cardiography suffers from limited acoustic windows and
angle dependency. Cardiovascular magnetic resonance
(CMR) imaging overcomes the above limitations, and is
therefore the ideal tool for definitively assessing cardiac
geometry and remodeling. The objective of this study
was to comprehensively evaluate the relationship be-
tween obesity, ABP measurements and cardiac remodel-
ing in uncomplicated, asymptomatic children without
and with obesity. We hypothesized that ABP measure-
ments and obesity would both independently correlate
with CMR derived measures of cardiac remodeling
(mass, thickness, hypertrophy).
Methods
Study population
Children ages 8–17 years were prospectively recruited
from the University of Kentucky (the High BMI Diagnos-
tic Clinic, and the Center for Clinical and Translational
Science volunteer database) and Geisinger Medical Cen-
ter. Body mass index (BMI) percentiles for age and gender
based on the Centers for Disease Control growth charts
[21] were used to group the children into different weight
categories: obese/overweight (BMI ≥85th percentile) and
healthy weight (BMI 5th–85th percentile). Children were
excluded if they had 1) diabetes, 2) diagnosed hypertension
or history of taking medications that could alter BP, 3) his-
tory of heart disease, or 4) contraindications for CMR (in-
cluding a waist circumference > 125 cm due to the
circumference limitation of the scanner bore). A subset
(one third) of the subjects were included in a previous study
on LV remodeling and cardiac strain [7].
Clinical assessment
Clinical assessment took place at the time of the CMR
scan. Height and weight were measured twice using a
digital scale and the average values were used to
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determine age and sex specific BMI (weight/height2 in
kg/m2) percentiles. Resting BP was measured manually
by auscultation using an appropriately sized cuff after
10 min of rest. Three measurements were taken, and the
average of the last two was reported as the clinic BP. The
clinic BP was classified into normal, pre-hypertensive or
hypertensive based on established reference values for age,
height and sex. All children had a normal 12-lead
electrocardiogram.
CMR imaging
A CMR study was performed on all subjects on a 3 T
(Trio, Siemens Healthineers, Erlangen, Germany) using
6-element chest and 24-element spine coils. Standard
elecrocardiogram-gated balanced steady-state free-
precession (bSSFP) images were acquired during 10–15 s
breath-holds to assess cardiac geometry and remodeling.
Two-chamber, four-chamber and a stack of short-axis
bSSFP images spanning both ventricles were acquired. 7–
11 short-axis images were acquired depending on the size
of the heart. Acquisition parameters included 3.16
−3.37 ms repetition time, 1.3−1.5 ms echo time, [292
−400] x [340−400] mm2 field of view, [208−256] × 256
image matrix, 50° flip angle, 16.4−49.9 ms temporal reso-
lution, 8 mm slice thickness, and 0−3.7 mm slice gap.
Cardiac remodeling
To assess cardiac geometry and remodeling, both LV
and right ventricular (RV) endocardial boundaries were
manually delineated on end-diastolic and end-systolic
frames of the bSSFP images. LV epicardial boundaries
were defined on an end-diastolic frame to quantify LV
mass and wall thickness. LV end-diastolic (EDV) and
end-systolic (ESV) volumes were computed from recon-
structed 3D endocardial surfaces (Figure 1) using a cus-
tom algorithm written in MATLAB (The Mathworks,
Natick, Massachusetts, USA) as previously described [7].
A 3D epicardial surface was reconstructed to quantify
LV myocardial mass assuming a myocardial density of
1.05 g/mL. To account for somatic growth, LV mass was
indexed to height2.7 (LVMI), which has been shown to
best predict cardiac risk compared to other methods of
normalization [22]. LV myocardial wall thickness was
computed as the equipotential distance between the
epicardial and endocardial surfaces for over 2000 points
on the 3D surfaces [23]. The average of all distances was
reported as the mean thickness. RV EDV and ESV were
calculated using Simpson’s rule using contours from all
short-axis images. RV myocardial mass (indexed to
height2.7, RVMI) was calculated from the end-diastolic
frame assuming a myocardial density of 1.05 g/mL. LV
and RV ejection fraction were also derived ((EDV-ESV)/
EDVx100%).
To study the relationship between hypertrophic cardiac
remodeling and BP measurements, cutoff values of LVMI
(27.52 g/m2.7) and mass/volume ratio (0.69), defined from
a previous study [7], were used to classify all subjects into
one of the four LV remodeling types: normal geometry,
concentric remodeling, eccentric hypertrophy and con-
centric hypertrophy (Figure 2A). Furthermore, to repre-
sent the presence of concentric hypertrophy with a
continuous variable, principal component analysis using
LVMI and mass/volume was used to derive a hypertrophy
score. LVMI and mass/volume were normalized by the
mean and standard deviation (SD) of the healthy controls,
and hypertrophy score was defined as the projection onto
the first principal component (Figure 2B). A lower hyper-
trophy score corresponds to a more normal geometry,
whereas a higher score corresponds to more concentric
hypertrophy.
Ambulatory blood pressure monitoring
Following the CMR scan, ABP monitoring was con-
ducted using a SunTech Oscar 2 24-h ABP device and
Orbit BP cuff (SunTech Medical, Inc. Morrisville, North
Carolina, USA). An appropriate cuff based on the sub-
ject’s arm circumference was chosen from four available
sizes, and placed tightly on the subject’s non-dominant
arm. The device would inflate shortly after activation and
take two readings within the first 5 min, which a member
of the study team used to confirm correct functionality.
Stack of 
Short-axis Images
Two-chamber
Long-axis Image
Four-chamber 
Long-axis Image
3D Reconstruction 
of the Left Ventricle
a b c d
Fig. 1 Three-dimensional left ventricular (LV) endocardial and epicardial surfaces (d) were reconstructed using a stack of short-axis bSSFP images
(a), a two-chamber view (b), and a four-chamber view (c)
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These initial readings were not included in subsequent
analysis. The device was programmed to take a reading
every 20–30 min between 7:00 am and 10:00 pm, and
every 30–45 min from 10:00 pm to 7:00 am. Daytime and
nighttime for each subject were determined by self-
reported sleep and wake times from diaries. Subjects were
advised to follow ordinary daily activities but avoid vigor-
ous exercise and to relax the arm during the inflation and
deflation of the cuff. Measurements were automatically re-
peated if the device failed to take a reading.
After 24 h, the device and cuff were removed. Data
were downloaded using the manufacturer’s software
AccuWin Pro, and analyzed according to the Ameri-
can Heart Association (AHA) statement [19]. Subjects
(n = 4) with fewer than 14 daytime readings or fewer
than 7 nighttime readings were excluded from ana-
lysis. Height- and sex- specific normative reference
values from a European cohort provided by the
German Working Group on Pediatric Hypertension
were used [24]. BP load was defined as the percent-
age of measurements that were above the 95th per-
centile for height and sex. Mean systolic BP (SBP)
and diastolic BP (DBP), and systolic and diastolic
loads were computed for the entire 24-h period, day
time and night time. In addition, systolic and diastolic
dipping were calculated as the percent drop in mean
nighttime BP relative to mean daytime BP ((BPday-
BPnight)/BPdayx100%). A dipping of at least 10% was
considered normal [19]. BP staging was determined
based on classification criteria from the American
Heart Association statement [19] using both clinic BP
and ABP measurements and summarized as follows:
1. Normal BP: clinic BP <90th percentile, ABP <95th
percentile and BP load <25%;
2. Masked hypertension: clinic BP <95th percentile,
ABP >95th percentile and BP load ≥25%;
3. Pre-hypertension: clinic BP ≥90th percentile, ABP
<95th percentile and BP load ≥25%;
4. Ambulatory or sustained hypertension: both clinic
BP and ABP >95th percentile and BP load ≥25%.
Statistics
Continuous variables were reported as mean ± SD. The
two-sample student’s t-test was used to compare differences
between the obese/overweight and healthy groups. Categor-
ical variables were compared between groups using either
Pearson’s Chi-Square or Fisher’s exact tests. Linear regres-
sion, with adjustment for age, was used to estimate the dif-
ferences in measures of cardiac remodeling and ABP
parameters between groups. Correlations between BMI z-
score, BP parameters and measures of cardiac remodeling
were estimated using Pearson’s correlation coefficient. Step-
wise linear regression was performed to determine inde-
pendent predictors for measures of cardiac remodeling.
Akaike information criterion (AIC) was used for model se-
lection, i.e. the model with the smallest AIC was selected as
the final model by the stepwise regression. Statistical signifi-
cance level was set to p < 0.05. All statistical analyses were
performed in R [25] (Version 3.3.1).
Results
Demographics and clinical assessment
Seventy-two children were enrolled in the study. Of
those, 4 did not complete ABP monitoring and were ex-
cluded from data analysis. A total of 68 subjects, includ-
ing 31 obese/overweight (median age: 12.5 years,
interquartile range: 11.3–14.3 years, 43% female) and 37
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Fig. 2 Principal component analysis (PCA) was used to represent left
ventricular (LV) concentric hypertrophy. LV remodeling types were
determined using previously defined cutoff values of LV mass index
(LVMI) and mass/volume ratio (a). LVMI and mass/volume ratio were
normalized by subtracting the mean and divided by the standard
deviation derived from the healthy controls, and then hypertrophy
scores were defined as the projections (red dot) along the 1st
principal component direction using PCA (b)
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healthy weight (median age: 13.3 years, interquartile
range: 12.1–15.6 years, 55% female) children, completed
both CMR and ABP monitoring and were included in
subsequent analysis. Table 1 summarizes the demo-
graphics and clinical assessment of the study population.
Age, sex and height were comparable between the two
groups.
Cardiac remodeling
LVMI (27 ± 4 vs 22 ± 3 g/m2.7, p < 0.001), mean myo-
cardial thickness (5.6 ± 0.9 vs 4.9 ± 0.7 mm, p < 0.001)
and mass/volume ratio (0.69 ± 0.1 vs 0.61 ± 0.06,
p < 0.001) were significantly larger in obese/overweight
children compared to healthy controls (Table 2). A rep-
resentative example of LV remodeling is shown in Fig. 3.
In addition, obese/overweight children had larger RVMI
(7.9 ± 1.2 vs 6.5 ± 1.0 g/m2.7, p < 0.001). LV and RV
EDV and ESV were comparable between the groups.
There were no significant differences in LV or RV ejec-
tion fractions (Table 2).
More than half of the obese/overweight children had
some form of LV remodeling: 11 (35%) had concentric
hypertrophy, 1 (3%) had concentric remodeling, 4 (13%)
had eccentric hypertrophy, and the remaining 15 (49%)
had normal geometry. The hypertrophy score was also
higher in the obese/overweight children compared to the
healthy weight group (1.1 ± 2.2 vs −0.96 ± 1.1, p < 0.001,
Table 2).
Blood pressure measurements
Compared to healthy controls, obese/overweight chil-
dren had elevated clinic SBP (117 ± 11 vs 111 ± 8 mmHg,
p = 0.001) and mean arterial pressure (89 ± 7 vs
85 ± 6 mmHg, p = 0.005) (Table 1). Results of the ABP
measurements are summarized in Table 3. SBP and sys-
tolic load in obese/overweight children was elevated for
all time periods compared to healthy controls. Specific-
ally, 24 h SBP was elevated by 8% (p = 0.004), while sys-
tolic load almost doubled that of the healthy controls
(p = 0.001). In addition, obese/overweight children had
slightly higher nighttime DBP (59 ± 9 vs 56 ± 6 mmHg,
p = 0.046) and 24 h diastolic load (19 ± 17% vs
12 ± 11%, p = 0.04), while 24 h and daytime DBP and
daytime and nighttime diastolic load were comparable to
healthy controls. Systolic dipping (10 ± 6% vs 13 ± 7%,
p = 0.09) and diastolic dipping (15 ± 9% vs 19 ± 8%,
p = 0.07) trended lower in obese/overweight children.
Blood pressure classifications
BP classification was significantly different between obese/
overweight and healthy weight children (p < 0.001,
Table 4). Eight out of the 31 (26%) obese/overweight chil-
dren had ambulatory hypertension compared to none in
the healthy weight group. The prevalence of masked
hypertension was 32% in obese/overweight children, com-
pared to 16% in healthy controls. The prevalence of pre-
hypertension was low and comparable between the groups
(6% in obese/overweight vs 5% in healthy weight). Only
36% of obese/overweight children had normal BP.
Correlations between blood pressure, obesity and cardiac
remodeling
Results of the univariate linear regression between ABP
measurements, BMI z-score and measures of cardiac
Table 1 Demographics and clinical parameters (mean ± SD, and median [interquartile range]) of the study population
Obese/Overweight
n = 31
Healthy
n = 37
p*
Age (years) 12.8 ± 2.5
12.5 [11.3, 14.3]
13.4 ± 2.6
13.3 [12.1, 15.6]
0.31
Sex (M/F) 14/17 21/16 0.47
Weight (kg) 75 ± 21
74 [56, 92]
47 ± 13
49 [37, 56]
<0.001
Height (cm) 158 ± 13
157 [149, 165]
156 ± 14
158 [147, 166]
0.56
Body Mass Index (kg/m2) 29 ± 6
29 [25, 33]
19 ± 3
19 [18, 21]
<0.001
Body Mass Index Percentile 96 ± 4
98 [95, 99]
47 ± 26
52 [27, 66]
Body Mass Index z-score 2.0 ± 0.5
2.2 [1.7, 2.3]
−0.2 ± 0.9
0.1 [−0.6, 0.4]
Heart rate (beats/min) 72 ± 9 70 ± 9 0.32
Systolic blood pressure (mmHg) 117 ± 11 111 ± 8 0.001
Diastolic blood pressure (mmHg) 75 ± 6 72 ± 5 0.07
Mean arterial pressure (mmHg) 89 ± 7 85 ± 6 0.005
*p values for systolic, diastolic and mean blood pressures are adjusted for age
Jing et al. Journal of Cardiovascular Magnetic Resonance  (2017) 19:86 Page 5 of 11
remodeling are reported in Table 5 where only signifi-
cant correlations are shown. BMI z-score moderately
correlated to all measures of cardiac remodeling (LVMI:
r = 0.62; mean thickness: r = 0.49; mass/volume:
r = 0.43; hypertrophy score: r = 0.58; all p < 0.001).
LVMI and hypertrophy score correlated with all mea-
sures of SBP and systolic load, but most strongly with
24 h SBP (LVMI: r = 0.36, p = 0.003; hypertrophy score:
r = 0.44, p < 0.001). Mean thickness and mass/volume
correlated to all BP and BP load measurements except
for daytime DBP. The strongest correlations were also
with 24 h SBP (thickness: r = 0.60, p < 0.001; mass/vol-
ume: r = 0.44, p < 0.001). There was also a weak negative
correlation between mass/volume and systolic dipping
(r = −0.26, p = 0.04).
Multivariate linear regression
After adjusting for sex and height, BMI z-score and 24 h
SBP were independent predictors of LVMI (β=0.54 and
0.22) and hypertrophy score (β=0.47 and 0.36), while
nighttime SBP and BMI z-score were independent pre-
dictors of thickness (β=0.26 and 0.34) and mass/volume
ratio (β=0.35 and 0.31) (Table 6). Moreover, Fig. 4 shows
that two distinct regression models describe the relation-
ship between 24 h SBP and LVMI for obese/overweight
children and healthy weight children, indicating independ-
ent contributions of 24 h SBP and obesity to increased
LVMI. BMI z-score generally had stronger relationships
(higher β coefficients) with the measures of LV remodel-
ing compared to the ABP derived metrics.
Discussion
In the current study, we comprehensively investigated
the relationship between obesity, ambulatory blood pres-
sure and measures of cardiac remodeling using CMR in
68 asymptomatic children. Major findings include: 1)
obese/overweight children have LV and RV remodeling,
Table 2 Cardiac geometry, ejection fraction and remodeling, mean ± SD or N(%)
Obese/Overweight
n = 31
Healthy
n = 37
p, age adjusted
LV geometry and function
LV mass index (g/m2.7) 27 ± 4 22 ± 3 <0.001
LV end-diastolic volume (mL) 137 ± 29 125 ± 36 0.07
LV end-systolic volume (mL) 51 ± 14 48 ± 15 0.25
LV mass/volume ratio 0.69 ± 0.10 0.61 ± 0.06 <0.001
LV mean thickness (mm) 5.6 ± 0.9 4.9 ± 0.7 <0.001
LV ejection fraction (%) 63 ± 4 62 ± 4 0.44
LV remodeling
LV hypertrophy score 1.1 ± 2.2 −0.96 ± 1.1 <0.001
LV remodeling types* <0.001
Normal geometry 15 (49) 31 (84)
Concentric remodeling 1 (3) 3 (8)
Eccentric hypertrophy 4 (13) 2 (5)
Concentric hypertrophy 11 (35) 1 (3)
RV geometry and function
RV mass index (g/m2.7) 7.9 ± 1.2 6.5 ± 1.0 <0.001
RV end-diastolic volume (mL) 151 ± 37 141 ± 42 0.20
RV end-systolic volume (mL) 59 ± 18 55 ± 20 0.37
RV ejection fraction (%) 61 ± 6 61 ± 4 0.94
LV left ventricular, RV right ventricular
*p value for LV remodeling types is not adjusted for age
6.3mm
10.1mm
Healthy Obese
Fig. 3 A representative example of LV remodeling (wall thickening)
from an obese male with concentric hypertrophy compared to an
age-matched healthy male
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as evidenced by increased LVMI, LV wall thickness, LV
mass/volume and RVMI; 35% of obese/overweight chil-
dren have concentric LV hypertrophy; 2) ambulatory
SBP, DBP and BP loads are elevated in obese/overweight
children; 26% of obese/overweight children have ambu-
latory hypertension and 32% have masked hypertension;
3) BMI z-score, systolic BP and BP load correlate with
all measures of LV remodeling (LVMI, thickness, mass/
volume, hypertrophy score); 4) BMI z-score and 24 h
SBP independently associate with LVMI and the extent
of LV concentric hypertrophy.
Obesity-related hypertension using ambulatory blood
pressure monitoring
Hypertension is a common comorbidity in childhood
obesity [26]. In multiple cross-sectional and longitudinal
studies conducted in children, BMI has been shown to
have a strong effect on increases in BP that is greater
than all other considered factors [27–29]. Considering
the well-known effect of hypertension on cardiovascular
morbidity in adults [16], accurate assessment and diag-
nosis of obesity-related hypertension is critical to appro-
priately risk stratify these children and consider targeted
treatment. Clinic BP is a commonly used tool for screen-
ing subjects with hypertension. However, this single
measurement of BP may not reflect physiological varia-
tions in BP, leading to an inaccurate or missed diagnosis.
ABP monitoring provides a comprehensive evaluation of
the BP profile and is therefore superior to clinic BP in
detecting hypertension in obese children.
Based on American Heart Association criteria [19], 26%
of obese/overweight children had ambulatory/sustained
hypertension. This prevalence is lower than the 50–60%
range reported by previous studies [30–32], likely because
we only enrolled uncomplicated and asymptomatic sub-
jects without a clinical diagnosis of hypertension. These
criteria may similarly explain why we did not detect any
subjects with white coat hypertension, although a preva-
lence of 30–50% has been reported previously [33, 34].
Additionally, masked hypertension was detected in 32% of
obese/overweight and 16% of healthy weight children. The
true prevalence of masked hypertension is not well estab-
lished in the literature, ranging from 7% in the general
population [31] to 26% in subjects at risk for hypertension
[32]. The modest discrepancies may lie in the variations in
sample size and selection bias of the study population, and
Table 3 Ambulatory blood pressure monitoring measurements (mean ± SD)
Obese/Overweight
n = 31
Healthy
n = 37
p, age adjusted
24-h
24 h SBP (mmHg) 126 ± 15 117 ± 11 0.004
24 h DBP (mmHg) 66 ± 8 64 ± 6 0.19
24 h systolic load (%) 41 ± 28 22 ± 18 0.001
24 h diastolic load (%) 19 ± 17 12 ± 11 0.04
Daytime
Day SBP (mmHg) 130 ± 15 123 ± 11 0.01
Day DBP (mmHg) 70 ± 8 69 ± 7 0.58
Day systolic load (%) 41 ± 28 23 ± 17 0.001
Day diastolic load (%) 17 ± 16 13 ± 14 0.21
Nighttime
Night SBP (mmHg) 117 ± 17 107 ± 13 0.003
Night DBP (mmHg) 59 ± 9 56 ± 6 0.046
Night systolic load (%) 41 ± 31 20 ± 26 0.003
Night diastolic load (%) 22 ± 24 13 ± 15 0.06
Nocturnal Dipping
Systolic dipping (%) 10 ± 6 13 ± 7 0.09
Diastolic dipping (%) 15 ± 9 19 ± 8 0.07
SBP systolic blood pressure, DBP diastolic blood pressure
Table 4 Blood pressure classification, N(%)
Classification Obese/Overweight
n = 31
Healthy
n = 37
Total
n = 68
Normal 11 (36) 29 (79) 40 (59)
Masked hypertension 10 (32) 6 (16) 16 (23)
Pre-hypertension 2 (6) 2 (5) 4 (6)
Ambulatory hypertension 8 (26) 0 (0) 8 (12)
p < 0.001 between obese/overweight and healthy weight children
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a larger population may be needed to determine the true
prevalence of masked hypertension in children. Identifica-
tion of masked hypertension is important since these chil-
dren may have similar cardiovascular risk as those with
sustained hypertension [35, 36]. ABP monitoring is there-
fore an essential tool for risk stratification of hypertensive
children.
Obesity, blood pressure and cardiac remodeling
Cardiac remodeling, estimated by increased LVMI, wall
thickness and the presence of LV hypertrophy defined as
LVMI > 51 g/m2.7 using echocardiography [37], has been
widely used as a surrogate for target organ damage in
the pediatric population [13, 15, 38, 39]. Children with
increased LVMI and LV hypertrophy may be at in-
creased risk of cardiovascular disease and premature
death as adults [16]. Therefore, identifying mechanisms
underlying cardiac remodeling is essential for targeted
treatment.
Obesity and hypertension have both been related to
cardiac remodeling in children. Although obesity is
known to impact LV geometry independent of its associ-
ated risk factors such as insulin resistance and inflam-
matory biomarkers [8, 19, 38, 40], reports on the role of
hypertension in cardiac remodeling are controversial. In-
creased LVMI is often linked to hypertension assuming
the ventricular wall thickens to compensate for in-
creased afterload. Although most studies have shown
that after controlling for BMI z-score, ambulatory sys-
tolic BP and/or systolic load correlated with LVMI and/
or relative wall thickness [13–15, 32], a few studies found
no [38] or weak [34] associations between elevated BP and
increased LVMI or LV hypertrophy. An observational
study by Brady et al. [38] further showed that between
two clinic visits 12 months apart, despite increased LVMI
and prevalence of LV hypertrophy at the second visit,
change in BP was minimal; and that adiposity remained
the only factor independently associated with increased
LVMI after adjusting for multiple biomarkers. Similarly, in
obese adults who lost weight through bariatric surgery,
decreases in LVMI and relative wall thickness were not as-
sociated with a reduction in BP [41]. This evidence
Table 5 Linear correlations between BMI z-score, ABP measurements and measures of left ventricular remodeling
LVMI LV Thickness LV Mass/Volume LV Hypertrophy score
r p r p r p r p
BMI z-score 0.62 <0.001 0.49 <0.001 0.43 <0.001 0.58 <0.001
Systolic
24 h SBP 0.36 0.003 0.60 <0.001 0.44 <0.001 0.44 <0.001
Day SBP 0.39 0.001 0.57 <0.001 0.41 <0.001 0.45 <0.001
Night SBP 0.34 0.005 0.57 <0.001 0.46 <0.001 0.43 <0.001
24 h systolic load 0.33 0.006 0.43 <0.001 0.36 0.003 0.37 0.002
Day systolic load 0.34 0.005 0.37 0.002 0.32 0.007 0.36 0.003
Night systolic load 0.31 0.01 0.44 <0.001 0.39 0.001 0.36 0.003
Systolic dipping −0.26 0.04
Diastolic
24 h DBP 0.27 0.03
Night DBP 0.24 0.046 0.31 0.01
24 h diastolic load 0.26 0.03 0.31 0.009
Night diastolic load 0.32 0.007 0.32 0.009
ABP ambulatory blood pressure, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, LVMI left ventricular mass index
Table 6 Multivariate linear regression (height and sex adjusted)
LVMI LV Thickness LV Mass/Volume LV Hypertrophy Score
β (SE) p β (SE) p β (SE) p β (SE) p
BMI z-score 0.54
(0.10)
<0.001 0.34 (0.07) <0.001 0.31
(0.10)
0.004 0.47
(0.10)
<0.001
24 h SBP 0.22
(0.10)
0.03 0.36
(0.10)
<0.001
Night SBP 0.26 (0.08) 0.001 0.35
(0.11)
0.002
β: normalized coefficient, SE standard error, BMI body mass index, SBP systolic blood pressure, LVMI left ventricular mass index
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suggests that LV remodeling in obese children is mediated
through both BP dependent and independent pathways.
In the current study, to comprehensively evaluate the
contribution of obesity and blood pressure to cardiac
remodeling in obese children, we used CMR with 3D
surface reconstructions to assess LV geometry and
remodeling, and defined a continuous variable (the
hypertrophy score) to represent the presence of LV
hypertrophy. CMR is superior to 2D transthoracic echo-
cardiography for quantification of cardiac geometry and
remodeling due to better image quality and inter-
observer and inter-test reproducibility [42], while echo-
cardiography suffers from limited acoustic windows and
angle dependency. Note that the reported LVMI in the
current study is smaller than the previously defined LV
hypertrophy threshold value of 51 g/m2.7, probably due
to multiple reasons. First, the 51 g/m2.7 threshold was
defined using echocardiography, and is not directly ap-
plicable to CMR since discrepancies between CMR and
echocardiography have been reported [43]. Second, our
study was conducted in children, while the 51 g/m2.7
threshold was defined in adults. Therefore, we used
threshold values of LVMI and mass/volume ratio derived
from a previous CMR study in healthy children to
categorize the different remodeling types [7].
Consistent with most previous studies, we found that
both BMI z-score and systolic BP (24 h or nighttime)
are independently associated with LVMI, thickness,
mass/volume and hypertrophy score. Moreover, com-
pared to systolic BP, BMI z-score may be more strongly
associated with measures of cardiac remodeling, espe-
cially for LVMI. When plotting LVMI against 24 h sys-
tolic BP, LVMI for obese/overweight children fit on a
different line from healthy weight children. This finding
suggests that although LV remodeling is affected by
elevated BP to some extent, it may not be the most im-
portant contributor. Thus, while antihypertensive treat-
ment may be warranted in children with hypertension,
additional interventions targeted at weight loss or path-
ways involved in other obesity co-morbidities may be
necessary to effectively reverse or prevent cardiac re-
modeling and future cardiovascular risk.
Limitations
In this cross-sectional study, contributions of obesity
and ABP to changes in measures of cardiac remodeling
could not be investigated. Future studies with longitu-
dinal follow-up are required to address this issue. In
addition, most subjects in the current study were white.
As racial differences have been shown to affect ABP in
children [44], results observed in the current study may
not hold true for a more generalized pediatric popula-
tion. However, a previous study has shown that race/eth-
nicity does not affect the relationship between BP and
LVMI [14]. Since gender also impacts the relationship
between obesity, BP and cardiac remodeling [45], we in-
cluded gender as a dependent variable in the multivari-
ate model. However, we did not find significant
correlations between gender and measures of cardiac re-
modeling in the current study.
Multiple statistical tests were performed in the current
study, however, we chose not to adjust for multiple test-
ing and to leave it to the reader to interpret the statis-
tical results in the presence of multiple testing. The
associations between ABP and cardiac outcomes were
investigated using linear models, it is possible that the
associations were nonlinear. However, an assessment of
the linearity assumption for the continuous variables
was performed and all were found to be linear.
Conclusions
In children, both the degree of obesity and elevated am-
bulatory blood pressure are independently associated
with increased LVMI and wall thickness as well as the
presence of concentric hypertrophy. This suggests that
interventions targeted at weight loss or pathways in-
volved in obesity-associated co-morbidities such as
hypertension may be effective in reversing or preventing
cardiac remodeling and future cardiovascular risk.
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